US Prepares $2.8 Billion Bomb Sale to Israel Amid Humanitarian Concerns
The United States is preparing to sell approximately $2.8 billion worth of heavy bombs to Israel, marking the largest single sale of such munitions in recent years. The deal includes 40,000 bombs, specifically 20,000 MK-84 and 20,000 BLU-117 bombs, along with 20,000 I-2000 Penetrator warheads designed to breach fortifications. The MK-84, known as the "Hammer," is a powerful weapon capable of penetrating concrete and causing widespread destruction. This sale has been informally presented to relevant congressional committees.
A US official stated that all foreign arms sales undergo a proper review process, declining to comment on ongoing deals. Israel's embassy has not yet responded to requests for comment. The value of this transaction surpasses previous arms deals for similar weight munitions under both the Biden and Trump administrations, including a $2.04 billion sale in 2025 that bypassed standard congressional review.
Reports indicate that these types of bombs have been used by Israel hundreds of times in Gaza and Lebanon, contributing significantly to casualties. Israel has faced criticism for routinely deploying MK-84 bombs in areas designated as safe for civilians in Gaza. Trevor Ball, a former bomb disposal technician, noted their effectiveness in destroying buildings.
The MK-84 was the only weapon system whose delivery to Israel was halted by the Biden administration during the Gaza war due to concerns over civilian casualties, a suspension that occurred in spring 2024. Former President Trump is expected to reverse this policy upon taking office in January 2025.
Concerns have been raised by experts like Brian Finnegan of the International Crisis Group regarding the potential use of these weapons in densely populated areas, questioning the legitimacy of Israeli military targets. He added that the timing of the sale, regardless of intent, signals confidence in Israel, potentially complicating efforts to de-escalate regional tensions. The Trump administration is reportedly pressuring Senate and House foreign relations committees to approve the deal.
Separately, a report from the Congressional Budget Office (CBO) estimates the war in Iran has cost the US approximately $38 billion to date, with an additional $3 billion monthly expenditure projected. This is expected to increase inflation by 0.5% in early 2027 and has strained US ammunition stockpiles, potentially impacting its ability to respond to future conflicts. The CBO noted that replenishing these stocks could take five years.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.